The Local Registration Holder Requirement in Argentina
Updated: 2026-11-12 · GRZAN Regulatory Team · Verification date 2026-10-20
1. Key takeaways
Argentina does not accept direct filings from foreign manufacturers. A registration application must be submitted and held by a locally established company in Argentina — the importer or legal representative — that is legally registered in the country and holds operating qualification under Disposición ANMAT 2319/2002, acting as the applicant (solicitante). The foreign manufacturer cannot appear before ANMAT in its own name at any point in the process.
This means that three core assets all belong to the local entity: the registration certificate, the right to import, and the official communication channel with ANMAT. A foreign manufacturer cannot hold any of the three in its own hands. Choosing who will hold the registration is, in substance, choosing the compliance foundation on which the company’s entire Argentina market position will rest — a decision that shapes every later change, transfer, and dispute.
The practical consequence of this rule is that every foreign manufacturer entering Argentina must first decide who will stand in front of the regulator on its behalf. The applicant must be the qualified local company itself: it signs the application, receives the certificate, appears in the public records, and communicates with ANMAT. Nothing in the framework lets the foreign manufacturer hold these functions directly, which is why the choice of holder — and the contract that governs that choice — deserves as much attention as the technical dossier itself.
2. Legal basis
The instruments below establish who may act as applicant, what the manufacturer’s authorization must contain, and the GMP obligations of the local holder.
| Instrument | Reference / number | Publication date | Provisions |
|---|---|---|---|
| Authorization of operating qualification for manufacturing/import enterprises | Disposición ANMAT 2319/2002 (T.O. 2004) | 2002 (consolidated text 2004) | Applicant eligibility and qualification provisions |
| MERCOSUR technical regulation on medical device registration | GMC/RES 25/21 | October 13, 2021 | Part III, Article 6 (manufacturer’s authorization declaration) |
| Domestic implementing instrument | Disposición ANMAT 64/2025 | Published in the Official Gazette on January 13, 2025 | Registration applicant provisions |
| Good Manufacturing Practices | Disposición ANMAT 3266/2013 | 2013 | GMP provisions for the local registration holder |
3. Expert insights
Insight 1: the foreign manufacturer’s legal presence in Argentina is achieved through an authorization. The manufacturer’s authorization declaration required by Article 6 of Part III of GMC 25/21 is the legal instrument by which the foreign manufacturer authorizes the Argentine importer to represent it and market its products in Argentina. The boundaries of the manufacturer’s rights are defined entirely by this authorization document — if the scope of authorization is drafted narrowly, later changes and enforcement of rights will be correspondingly constrained.
Insight 2: the registration holder is not the distributor, yet in practice the two are often bundled. Argentine regulation only requires that the holder be a qualified local company; it does not require the holder to perform distribution functions. Nevertheless, most foreign companies, for convenience, simply appoint their distributor as holder — which couples regulatory assets to a commercial relationship that may not last as long as the registration itself.
Insight 3: the identity of the registration holder determines the cost of changing holders. Replacing the holder requires a certificate transfer procedure involving re-notarized authorizations, document updates and fees. If the original holder is a distributor whose interest is anchored in commercial advantage, any change in the cooperation relationship leaves the manufacturer in a highly passive position during the transfer.
Because the holder relationship is contractual as much as regulatory, most of the protection a manufacturer can build is built at the drafting stage, before any filing is made. The recommendations below concentrate on the agreement architecture and on the authorization document itself, since these are the two instruments that determine how much control the manufacturer keeps over its regulatory assets once the certificate has been issued and the relationship has begun.
4. Practical recommendations
- Separate the three roles expressly in the agreement. Distinguish the registration holder (titular), the importer (importador) and the distributor (distribuidor), and avoid the default of merging all three roles into one party.
- Include every required element in the authorization. The manufacturer’s authorization declaration must be valid for 2 years from its issuance, must expressly authorize the Argentine importer to represent the manufacturer and market its products in Argentina, must state the full legal names and complete addresses of both parties, and must be legalized or apostilled with a translation attached.
- Agree on dossier ownership and access rights. Who keeps the technical dossier, whether the manufacturer may retrieve it at any time, and how it is handed over when the cooperation ends must be fixed in writing in the agreement.
- Prefer an independent, stable holder. Where the manufacturer cannot maintain its own subsidiary, appoint a third-party professional registration holder and decouple the regulatory assets from the commercial channel.
5. Verification checklist
Confirm each item below before signing a holder agreement or filing an application.
- □ It has been confirmed that the applicant is an Argentine local company holding 2319/2002 qualification
- □ The manufacturer’s authorization declaration states both parties’ full names and complete addresses and has been authenticated
- □ The authorization declaration was issued less than 2 years ago and remains within its validity period
- □ The agreement distinguishes the holder, the importer and the distributor
- □ Custody of the technical dossier and the manufacturer’s access rights have been agreed
- □ The independence of the holder has been assessed (whether it is tied to distribution interests)
Revisit this checklist whenever the holder relationship changes: a new holder, a change in the holder’s qualification status, or a change in the scope of the authorization all reopen the questions above. Keeping the answers current protects the certificate at least as much as the original filing did, and it prevents small contractual gaps from turning into transfer disputes later.
Regulatory information verified as of October 29, 2026.
In Argentina, GRZAN operates a wholly-owned subsidiary that can act as the registration holder and importer for foreign manufacturers, directly handling classification assessment, pathway selection, GMP and CFS documentation chains, Spanish-language technical documentation and labeling localization, HELENA submissions and deficiency responses, as well as BONITA import notifications, ARGOS vigilance system operation, change maintenance and 5-year renewal planning.
The GRZAN regulatory team consists of professionals with many years of hands-on international registration experience and tracks the developments of regulatory authorities worldwide. All published content follows the drafting standard of conclusions first, traceable legal basis, and verifiable figures. For an Argentina or MERCOSUR market-access plan tailored to a specific product, contact the GRZAN regulatory team at info@grzanglobal.com.
Disclaimer
Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.
About GRZAN
GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.
GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.
Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.
What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.
Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.
Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.
Take your devices global with GRZAN
We work with manufacturers worldwide to open new markets with a clear regulatory pathway.
Contact us